Polar Asset Management Partners Inc. Castle Biosciences Inc Transaction History

Polar Asset Management Partners Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $1.1 Million - $1.54 Million	60,800 New	60,800 $1.35 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $648,508 - $1.19 Million	53,200 New	53,200 $1.15 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $1.94 Million - $3.21 Million	107,100 New	107,100 $2.52 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $3.73 Million - $6.45 Million	-95,504 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $1.11 Million - $1.43 Million	-18,400 Reduced 16.15%	95,504 $6.35 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $5.7 Million - $8.75 Million	113,904 New	113,904 $8.35 Million

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $724M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.